Novelis Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Novelis Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2012 to Q3 2024.
  • Novelis Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2024 was $689M, a 2.82% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $689M -$20M -2.82% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $698M -$15M -2.1% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $696M -$15M -2.11% Mar 31, 2024 10-K 2024-05-06
Q4 2023 $708M -$16M -2.21% Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $709M -$14M -1.94% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $713M -$17M -2.33% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $711M -$52M -6.82% Mar 31, 2023 10-K 2024-05-06
Q4 2022 $724M -$106M -12.8% Dec 31, 2022 10-Q 2023-02-06
Q3 2022 $723M -$109M -13.1% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $730M -$92M -11.2% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $763M -$58M -7.07% Mar 31, 2022 10-K 2024-05-06
Q4 2021 $830M +$11M +1.34% Dec 31, 2021 10-Q 2022-02-07
Q3 2021 $832M +$18M +2.21% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $822M +$15M +1.86% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $821M +$66M +8.74% Mar 31, 2021 10-K 2024-05-06
Q4 2020 $819M Dec 31, 2020 10-Q 2021-02-03
Q3 2020 $814M Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $807M Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $755M +$13M +1.75% Mar 31, 2020 10-K 2023-05-10
Q1 2019 $742M +$15M +2.06% Mar 31, 2019 10-K 2022-05-11
Q4 2018 $745M +$49M +7.04% Dec 31, 2018 10-Q 2019-02-05
Q3 2018 $738M +$55M +8.05% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 $733M +$52M +7.64% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $727M +$47M +6.91% Mar 31, 2018 10-K 2021-05-12
Q4 2017 $696M +$4M +0.58% Dec 31, 2017 10-Q 2018-02-01
Q3 2017 $683M +$16M +2.4% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $681M +$51M +8.1% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $680M +$67M +10.9% Mar 31, 2017 10-K 2020-05-07
Q4 2016 $692M +$94M +15.7% Dec 31, 2016 10-Q 2017-02-07
Q3 2016 $667M +$94M +16.4% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $630M +$79M +14.3% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $613M +$85M +16.1% Mar 31, 2016 10-K 2017-05-10
Q4 2015 $598M +$95M +18.9% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $573M +$100M +21.1% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $551M +$122M +28.4% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $528M +$102M +23.9% Mar 31, 2015 10-K 2016-05-10
Q4 2014 $503M +$102M +25.4% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 $473M +$97M +25.8% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $429M +$71M +19.8% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $426M +$109M +34.4% Mar 31, 2014 10-K 2015-05-12
Q4 2013 $401M +$113M +39.2% Dec 31, 2013 10-Q 2014-02-10
Q3 2013 $376M +$97M +34.8% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $358M +$84M +30.7% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 $317M +$66M +26.3% Mar 31, 2013 10-K 2014-05-16
Q4 2012 $288M Dec 31, 2012 10-Q 2013-02-12
Q3 2012 $279M Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $274M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $251M Mar 31, 2012 10-K 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.